COVID-19: combining antiviral and anti-inflammatory treatments - PubMed (original) (raw)

Comment

COVID-19: combining antiviral and anti-inflammatory treatments

Justin Stebbing et al. Lancet Infect Dis. 2020 Apr.

No abstract available

PubMed Disclaimer

Comment in

• Baricitinib for COVID-19: a suitable treatment?
  Favalli EG, Biggioggero M, Maioli G, Caporali R. Favalli EG, et al. Lancet Infect Dis. 2020 Sep;20(9):1012-1013. doi: 10.1016/S1473-3099(20)30262-0. Epub 2020 Apr 3. Lancet Infect Dis. 2020. PMID: 32251638 Free PMC article. No abstract available.
• Baricitinib for COVID-19: a suitable treatment? - Authors' reply.
  Richardson PJ, Corbellino M, Stebbing J. Richardson PJ, et al. Lancet Infect Dis. 2020 Sep;20(9):1013-1014. doi: 10.1016/S1473-3099(20)30270-X. Epub 2020 Apr 3. Lancet Infect Dis. 2020. PMID: 32251639 Free PMC article. No abstract available.

Comment on

• Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.
  Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Rawling M, Savory E, Stebbing J. Richardson P, et al. Lancet. 2020 Feb 15;395(10223):e30-e31. doi: 10.1016/S0140-6736(20)30304-4. Epub 2020 Feb 4. Lancet. 2020. PMID: 32032529 Free PMC article. No abstract available.

References

1. 1. Peiris JSM, Chu CM, Cheng VCC, et al. Clinical progression and viral load in a community outbreak or coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767–1772. -PMC -PubMed
2. 1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. -DOI -PMC -PubMed
3. 1. Richardson P, Griffin I, Tucker C, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020;395:497–506. -PMC -PubMed
4. 1. Segler MHS, Preuss M, Waller P. Planning chemical syntheses with deep neural networks and symbolic AI. Nature. 2018;555:604–610. -PubMed
5. 1. Bekerman E, Neveu G, Shulla A, et al. Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. J Clin Invest. 2017;127:1338–1352. -PMC -PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science
  • Europe PMC
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • ClinicalTrials.gov

• Molecular Biology Databases

  • GlyGen glycoinformatics resource
  • Guide to Pharmacology